The "contraceptive revolution" of the 1960s and 1970s introduced totally new contraceptive options and launched an era of research and product development. Yet by the late 1980s, conditions had changed and improvements in contraceptive products, while very important in relation to improved oral contraceptives, IUDs, implants, and injectables, had become primarily incremental. Is it time for a second contraceptive revolution and how might it happen?
Contraceptive Research and Development explores the frontiers of science where the contraceptives of the future are likely to be found and lays out criteria for deciding where to make the next R&D investments.
The book comprehensively examines today's contraceptive needs, identifies "niches" in those needs that seem most readily translatable into market terms, and scrutinizes issues that shape the market: method side effects and contraceptive failure, the challenge of HIV/AIDS and other sexually transmitted diseases, and the implications of the "women's agenda."
Contraceptive Research and Development analyzes the response of the pharmaceutical industry to current dynamics in regulation, liability, public opinion, and the economics of the health sector and offers an integrated set of recommendations for public- and private-sector action to meet a whole new generation of demand.
Table of Contents
|2 The Need and Demand for New Contraceptive Methods||29-46|
|3 Contraceptive Technology and the State of the Science: Current and Near-Future Methods||47-93|
|4 Contraceptive Technology and the State of the Science: New Horizons||94-124|
|5 The Market for New Contraceptives: Translating Unmet Need Into Market Demand||125-165|
|6 The Translators: Sectoral Roles in Contraceptive Research and Development||166-235|
|7 Issues of Law, Regulation, Information, and the Environment for Contraceptive Research and Development||236-340|
|Appendix A: Female Methods||349-380|
|Appendix B: Male Methods||381-400|
|Appendix C: Immunocontraceptive Approaches||401-429|
|Appendix D: Barrier Methods and Mucosal Immunologic Approaches||430-473|
|Appendix E: Agendas and Participants in Committee Workshops||474-489|
|Appendix F: Committee Biographies||490-494|
The National Academies Press (NAP) has partnered with Copyright Clearance Center's Rightslink service to offer you a variety of options for reusing NAP content. Through Rightslink, you may request permission to reprint NAP content in another publication, course pack, secure website, or other media. Rightslink allows you to instantly obtain permission, pay related fees, and print a license directly from the NAP website. The complete terms and conditions of your reuse license can be found in the license agreement that will be made available to you during the online order process. To request permission through Rightslink you are required to create an account by filling out a simple online form. The following list describes license reuses offered by the National Academies Press (NAP) through Rightslink:
Click here to obtain permission for the above reuses. If you have questions or comments concerning the Rightslink service, please contact:
Rightslink Customer Care
Tel (toll free): 877/622-5543
To request permission to distribute a PDF, please contact our Customer Service Department at 800-624-6242 for pricing.
To request permission to translate a book published by the National Academies Press or its imprint, the Joseph Henry Press, please click here to view more information.